Integrated Net Interest Income from 2010 to 2026
| IDHC Stock | 0.64 0.01 1.59% |
Net Interest Income | First Reported 2010-12-31 | Previous Quarter -47 M | Current Value -44.7 M | Quarterly Volatility 35.3 M |
Check Integrated Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Integrated Diagnostics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 583 M, Selling General Administrative of 391.3 M or Selling And Marketing Expenses of 252.3 M, as well as many indicators such as . Integrated financial statements analysis is a perfect complement when working with Integrated Diagnostics Valuation or Volatility modules.
Integrated | Net Interest Income |
The evolution of Net Interest Income for Integrated Diagnostics Holdings provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Integrated Diagnostics compares to historical norms and industry peers.
Latest Integrated Diagnostics' Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of Integrated Diagnostics Holdings over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Integrated Diagnostics' Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Integrated Diagnostics' overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
Integrated Net Interest Income Regression Statistics
| Arithmetic Mean | (9,176,904) | |
| Geometric Mean | 20,884,191 | |
| Coefficient Of Variation | (384.88) | |
| Mean Deviation | 29,114,593 | |
| Median | 11,223,000 | |
| Standard Deviation | 35,320,526 | |
| Sample Variance | 1247.5T | |
| Range | 132.2M | |
| R-Value | (0.74) | |
| Mean Square Error | 607T | |
| R-Squared | 0.54 | |
| Significance | 0.0007 | |
| Slope | (5,158,361) | |
| Total Sum of Squares | 19960.6T |
Integrated Net Interest Income History
About Integrated Diagnostics Financial Statements
Integrated Diagnostics shareholders use historical fundamental indicators, such as Net Interest Income, to determine how well the company is positioned to perform in the future. Although Integrated Diagnostics investors may analyze each financial statement separately, they are all interrelated. The changes in Integrated Diagnostics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Integrated Diagnostics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | -47 M | -44.7 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Integrated Stock Analysis
When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.